SANTA CLARA, Calif.--GeneChip developer Affymetrix here and Roche Molecular Systems announced a joint effort to develop and market a new generation of diagnostic tests that combines Affymetrix's GeneChip DNA probe array technology with Roche's PCR gene amplification technology. The companies will initially develop diagnostic kits for applications in HIV drug resistance. The agreement provides a framework for the development of additional GeneChip diagnostic kits as the parties identify further product opportunities.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.